Acute Cerebellitis Following COVID-19: Alarming Clinical Presentation Challenged by Normal Paraclinical Findings.

IF 4.7 3区医学 Q1 INFECTIOUS DISEASES

Infectious Diseases and Therapy Pub Date : 2024-11-01 Epub Date: 2024-09-24 DOI:10.1007/s40121-024-01048-4

Samantha Poloni, Abdoulaye Hamani, Valentine Kassis, Pauline Escoffier, Beate Hagenkotter, Vincent Gendrin, Souheil Zayet, Timothée Klopfenstein

引用次数: 0

Abstract

We report the case of an acute cerebellitis following COVID-19 in 32-year-old man who presented with a life-threatening critical cerebellar syndrome contrasting with normal paraclinical findings. Despite this fulminant critical presentation, the patient fully recovered in 37 days after early treatment with high-dose steroids and intravenous immunoglobulins. This case highlights the need for clinicians to be aware of acute cerebellitis following COVID-19, despite normal laboratory, imaging and electroencephalography findings and the importance to start appropriate treatment as soon as possible.

查看原文本刊更多论文

COVID-19 后的急性小脑炎：临床表现惊人，临床旁检查结果却正常

我们报告了一例 32 岁男性因 COVID-19 感染急性小脑炎的病例，他出现了危及生命的重症小脑综合征，而临床旁检查结果却正常。尽管病情危重，但患者在接受大剂量类固醇和静脉注射免疫球蛋白的早期治疗后，37 天后完全康复。本病例强调，尽管实验室、影像学和脑电图检查结果正常，临床医生仍需警惕 COVID-19 引起的急性小脑炎，并应尽快开始适当的治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Infectious Diseases and Therapy Medicine-Microbiology (medical)

CiteScore

8.60

自引率

1.90%

发文量

136

审稿时长

6 weeks

期刊介绍： Infectious Diseases and Therapy is an international, open access, peer-reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of infectious disease therapies and interventions, including vaccines and devices. Studies relating to diagnostic products and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged. Areas of focus include, but are not limited to, bacterial and fungal infections, viral infections (including HIV/AIDS and hepatitis), parasitological diseases, tuberculosis and other mycobacterial diseases, vaccinations and other interventions, and drug-resistance, chronic infections, epidemiology and tropical, emergent, pediatric, dermal and sexually-transmitted diseases.